Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group
- 2 February 2017
- journal article
- research article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 73, 38-47
- https://doi.org/10.1016/j.ejca.2016.12.007
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Hypofractionation vs Conventional Radiation Therapy for Newly Diagnosed Diffuse Intrinsic Pontine Glioma: A Matched-Cohort AnalysisInternational Journal of Radiation Oncology*Biology*Physics, 2012
- Diffuse intrinsic pontine gliomas: A systematic update on clinical trials and biologyCancer Treatment Reviews, 2012
- Palliative Reirradiation for Progressive Diffuse Intrinsic Pontine GliomaAmerican Journal of Clinical Oncology, 2012
- Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastomaNature, 2012
- Treatment of recurrent diffuse intrinsic pontine glioma: the MD Anderson Cancer Center experienceJournal of Neuro-Oncology, 2011
- Clinical features, mechanisms, and management of pseudoprogression in malignant gliomasThe Lancet Oncology, 2008
- Reirradiation Tolerance of the Human BrainInternational Journal of Radiation Oncology*Biology*Physics, 2008
- BRAINSTEM LESIONS IN NEUROFIBROMATOSIS TYPE 1Neurosurgery, 2007
- Diffuse brainstem glioma in children: critical review of clinical trialsThe Lancet Oncology, 2006
- Survival Analysis Part II: Multivariate data analysis – an introduction to concepts and methodsBritish Journal of Cancer, 2003